Clinical Trials Browser

Phase 4 × Neoplasms × 90 days × Clear all

NCT02584933 2026-04-02

Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

Phase 4 Active not recruiting

Neoplasms

NCT06031233 2026-03-30

MINUTE

Phase 4 Recruiting

Neoplasms

NCT06183437 2026-03-30

STOP-MED CTRCD

Phase 4 Recruiting

Heart Failure, Neoplasms, Cardiotoxicity

NCT04948463 2026-03-20

ELSA-FN

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

NCT07486713 2026-03-20

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

Phase 4 Recruiting

CNSGastrointestinalOther hematologic neoplasm

Glioma, Neoplasms, Leukemia, Myeloid, Acute, Cholangiocarcinoma

NCT07279935 2026-03-19

REVIVE

Phase 4 Not yet recruiting

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT04813913 2026-02-06

VASCATAQ

Phase 4 Completed

Neoplasms